Orville Kolterman, M.D.
vivani | March 6, 2023
During his 20 year tenure at Amylin, Orville Kolterman, M.D. was instrumental in the development of first-in-class diabetes medicines, including SYMLIN, and BYETTA, BYDUREON and Myalept injections. Prior to his appointment as Senior Vice President & Chief Medical Officer, Dr.…